Senegalese Illegal Alien Detained and Deported from Poland After Defecating in Public at Popular Swimming Area
A Senegalese man has been deported from Poland following a shocking incident in the Valley of the Three Ponds in Katowice where he was caught on camera entering the water and relieving himself in front of onlookers.
A video that surfaced online several weeks ago showed a naked man entering the pool, squatting in the water, and apparently relieving himself in full view of other bathers. “He likely relieved himself in front of people relaxing by the water,” confirmed Lt. Sergeant Szymon Mościcki, a spokesperson for the Silesian Border Guard Branch.
The Senegalese ?? who ? in the Katowice lake has been caught and deported
— Ɐ ꓤ 2 ꓤ ???? (@A_Harasimowicz) August 22, 2024
Man resisted arrested, didn’t cooperate, didn’t sign docs, exposed himself & behaved obscenely
In Nov 23, he was caught staying in ?? illegally, instructed to leave ??, and was released
He didn’t do so ? pic.twitter.com/7PSZTWHV6H
The incident took place at the end of July, but it has since come to light that the Senegalese man had already been apprehended for unlawful residency in Poland last year. He was initially detained in September 2023 for illegal smuggling. During that arrest, he resisted, leading officers to use direct force. In November 2023, the head of the Border Guard station in Sosnowiec ordered the man to leave Poland and banned his reentry into the Schengen Zone for three years.
However, the migrant did not voluntarily leave the country, only to be apprehended again after the recent incident in Katowice.
On Tuesday, Aug. 21, the illegal migrant was escorted to Warsaw’s Okęcie Airport, from where he was flown back to Senegal.
The conservative news outlet Drzeczy.pl has raised questions as to why the man was not forcibly deported back in November 2023.
IDIOCRACY 2.0: Secretary of Commerce Claims The Department of Labor Does Not Exist
Alex Jones broke down how completely incompetent the Secretary of Commerce is after her cluelessness regarding her agency was exposed in an interview she did durning the DNC.
Don’t miss:
American Pharmaceutical Companies Accused of Carrying out Clinical Trials with Chinese Military
A bipartisan House committee has revealed that American pharmaceutical companies carried out drug trials in conjunction with the Chinese militaryfor more than 10 years.
The revelation came in a letter penned by Republican and Democratic leaders on the House Select Committee on the Chinese Communist Party (CCP) to the commissioner of the Food and Drug Administration (FDA), Robert Califf. In the letter, they pressed him to supply information about these clinical trials for new medications.
In their letter, they explained: “These collaborative research activities raise serious concerns that critical Intellectual Property is at risk of being transferred to the [Chinese military] or being co-opted under the People’s Republic of China’s National Security Law.”
They also expressed reservations about how much the results of clinical trials produced by China can be trusted.
The letter states that hundreds of clinical trials for drugs have been carried out at medical centers and hospitals in China that are affiliated with the People’s Liberation Army (PLA) at sites such as the PLA’s Air Force Medical University and the PLA’s General Hospital and Medical School.
One of the institutions is operated by the PLA’s Academy of Military Medical Sciences, an institution which the Department of Commerce has banned businesses in the United States from sharing technology with due to national security concerns.
Potential experimentation on Uyghur Muslims
The letter also draws attention to the fact that some of these trials took place in the Xinjiang Uyghur Autonomous Region, a place where China has been conducting genocide against the Muslims living there. Reports indicate that some have been subjected to organ harvesting, while female victims are routinely raped and sterilized in so-called “reeducation camps.”
As a result, it is impossible to determine whether those who participated in the trials did so willingly.
The committee’s letter notes: “Given this, we believe that U.S. biopharmaceutical entities could be unintentionally profiting from the data derived from clinical trials during which the CCP forced victim patients to participate.”
They are calling on the administration of President Joe Biden to carefully scrutinize these trials to protect our nation’s interests and the human rights of the Uyghurs.
“Given the historical suppression and medical discrimination against ethnic minorities in this region, there are significant ethical concerns around conducting clinical trials in (Xinjiang),” they cautioned.
The lawmakers posed a series of questions in their letter, including whether the FDA has ever reviewed clinical trials carried out in conjunction with the PLA or performed any on-site inspections of PLA facilities. They also ask how far back this practice goes and whether the FDA has ever notified an American biopharmaceutical firm that it carried out studies with the PLA.
They also asked the FDA to disclose the metrics it uses to assess the risks of intellectual property and technology transfers, giving them a deadline of Oct. 1 to respond.
One of the studies they focused on in their review of American clinical trials that included Chinese military hospital sites was for the Alzheimer’s disease drug donanemab by Eli Lilly. Another was a study of a liver cancer drug by Pfizer known as Inlyta.
A representative from the Chinese embassy in Washington told Reuters that the “accusations of intellectual theft” are “groundless” and denied that the country is guilty of genocide in Xinjiang.
Vote expected next month on BIOSECURE Act
The letter comes as the House prepares for a vote on the BIOSECURE Act next month. Legislation was introduced earlier this year that proposes putting a stop to federal contracts with specific Chinese biotech firms that are believed to present a national security risk to the U.S. It will stop pharmaceutical companies from doing business with the firms in question, which could significantly compromise their bottom line.
CRITICAL INTEL: Globalists Plotting to Assassinate Trump and Blame Iran, Triggering a Massive War & Martial Law at Home
On the Thursday show Alex Jones discussed how Trump fell into the trap of insinuating Iran tried to kill him, opening the door for the globalists to kill Trump, blame Iran AND get WWIII out of it.
Don’t miss:
BREAKING: Experts Believe Industrial Demand for Silver Based Batteries Will Push Silver to $200/Oz in the Near Future
Kirk Elliot joined Alex Jones on Thursday to update this incredible new use of silver in the world of precious metals.
Don’t miss:
Poland Becomes World’s Top Gold Buyer, Boosting National Currency
The National Bank of Poland (NBP) has steadily increased the country’s gold reserves, a move that has bolstered the Polish złoty as gold prices have surged.
On Wednesday, the NBP announced that its gold reserves reached 12.593 million ounces by the end of July, up from 12.133 million ounces the previous month. The central bank also reported that total official reserve assets stood at €190.535 billion at the end of July, slightly down from €195.515 billion a month earlier.
In June, NBP President Adam Glapiński revealed that the bank purchased 5 tons of gold this year and intends to continue buying until gold comprises 20 percent of the country’s foreign reserves, up from the current 13 percent.
Last year, the NBP purchased a record 130 tons of gold, so while this year’s acquisitions are smaller, the impact remains significant. Gold prices have surged 23 percent in U.S. dollar terms since the beginning of the year, breaking the barrier of $2,500 per ounce.
Poland leads global gold purchases in 2024, surpassing India, Turkey, Uzbekistan and the Czech Republic. With nearly 392 tons of gold, Poland now ranks 15th worldwide in gold holdings.
The increased gold reserves have tangible benefits: the złoty is now at its strongest against the euro since October 2008, further supported by the high gold coverage of the currency compared to the euro.